JPMorgan Downgrades Synageva BioPharma (GEVA) to Neutral

May 10, 2013 6:34 AM EDT Send to a Friend
Get Alerts GEVA Hot Sheet
Price: $118.89 +0.67%

Rating Summary:
    11 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 25 | Down: 40 | New: 35
Trade GEVA Now!
Join SI Premium – FREE
JPMorgan downgraded Synageva BioPharma (NASDAQ: GEVA) from Overweight to Neutral with a price target of $50.00 (from $57.00).

For an analyst ratings summary and ratings history on Synageva BioPharma click here. For more ratings news on Synageva BioPharma click here.

Shares of Synageva BioPharma closed at $45.79 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment